These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24809468)

  • 1. The characterization of a novel monoclonal antibody against CD93 unveils a new antiangiogenic target.
    Orlandini M; Galvagni F; Bardelli M; Rocchigiani M; Lentucci C; Anselmi F; Zippo A; Bini L; Oliviero S
    Oncotarget; 2014 May; 5(9):2750-60. PubMed ID: 24809468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD93 and dystroglycan cooperation in human endothelial cell adhesion and migration adhesion and migration.
    Galvagni F; Nardi F; Maida M; Bernardini G; Vannuccini S; Petraglia F; Santucci A; Orlandini M
    Oncotarget; 2016 Mar; 7(9):10090-103. PubMed ID: 26848865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival.
    Langenkamp E; Zhang L; Lugano R; Huang H; Elhassan TE; Georganaki M; Bazzar W; Lööf J; Trendelenburg G; Essand M; Pontén F; Smits A; Dimberg A
    Cancer Res; 2015 Nov; 75(21):4504-16. PubMed ID: 26363010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD93 Signaling via Rho Proteins Drives Cytoskeletal Remodeling in Spreading Endothelial Cells.
    Barbera S; Raucci L; Lugano R; Tosi GM; Dimberg A; Santucci A; Galvagni F; Orlandini M
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting the CD93-Multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium.
    Galvagni F; Nardi F; Spiga O; Trezza A; Tarticchio G; Pellicani R; Andreuzzi E; Caldi E; Toti P; Tosi GM; Santucci A; Iozzo RV; Mongiat M; Orlandini M
    Matrix Biol; 2017 Dec; 64():112-127. PubMed ID: 28912033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The small GTPase Rab5c is a key regulator of trafficking of the CD93/Multimerin-2/β1 integrin complex in endothelial cell adhesion and migration.
    Barbera S; Nardi F; Elia I; Realini G; Lugano R; Santucci A; Tosi GM; Dimberg A; Galvagni F; Orlandini M
    Cell Commun Signal; 2019 May; 17(1):55. PubMed ID: 31138217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma.
    Bao L; Tang M; Zhang Q; You B; Shan Y; Shi S; Li L; Hu S; You Y
    Biochem Biophys Res Commun; 2016 Aug; 476(4):467-474. PubMed ID: 27255994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.
    Khan KA; Naylor AJ; Khan A; Noy PJ; Mambretti M; Lodhia P; Athwal J; Korzystka A; Buckley CD; Willcox BE; Mohammed F; Bicknell R
    Oncogene; 2017 Nov; 36(44):6097-6108. PubMed ID: 28671670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidermal growth factor-like domain of CD93 is a potent angiogenic factor.
    Kao YC; Jiang SJ; Pan WA; Wang KC; Chen PK; Wei HJ; Chen WS; Chang BI; Shi GY; Wu HL
    PLoS One; 2012; 7(12):e51647. PubMed ID: 23272129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A natural small molecule harmine inhibits angiogenesis and suppresses tumour growth through activation of p53 in endothelial cells.
    Dai F; Chen Y; Song Y; Huang L; Zhai D; Dong Y; Lai L; Zhang T; Li D; Pang X; Liu M; Yi Z
    PLoS One; 2012; 7(12):e52162. PubMed ID: 23300602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TTAC-0001, a human monoclonal antibody targeting VEGFR-2/KDR, blocks tumor angiogenesis.
    Lee WS; Pyun BJ; Kim SW; Shim SR; Nam JR; Yoo JY; Jin Y; Jin J; Kwon YG; Yun CO; Nam DH; Oh K; Lee DS; Lee SH; Yoo JS
    MAbs; 2015; 7(5):957-68. PubMed ID: 25942475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis.
    Lugano R; Vemuri K; Yu D; Bergqvist M; Smits A; Essand M; Johansson S; Dejana E; Dimberg A
    J Clin Invest; 2018 Aug; 128(8):3280-3297. PubMed ID: 29763414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
    Takahashi N; Haba A; Matsuno F; Seon BK
    Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Binding of CD93 to Multimerin-2 Promotes Choroidal Neovascularization.
    Tosi GM; Neri G; Barbera S; Mundo L; Parolini B; Lazzi S; Lugano R; Poletto E; Leoncini L; Pertile G; Mongiat M; Dimberg A; Galvagni F; Orlandini M
    Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):30. PubMed ID: 32697305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic Activity of Acer tegmentosum Maxim Water Extract in Vitro and in Vivo.
    Kim EC; Kim SH; Piao SJ; Kim TJ; Bae K; Kim HS; Hong SS; Lee BI; Nam M
    J Korean Med Sci; 2015 Jul; 30(7):979-87. PubMed ID: 26130964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric identification of CD93 expression on naive T lymphocytes (CD4(+)CD45RA (+) cells) in human neonatal umbilical cord blood.
    Ikewaki N; Yamao H; Kulski JK; Inoko H
    J Clin Immunol; 2010 Sep; 30(5):723-33. PubMed ID: 20512406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
    Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
    Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth.
    Yan X; Lin Y; Yang D; Shen Y; Yuan M; Zhang Z; Li P; Xia H; Li L; Luo D; Liu Q; Mann K; Bader BL
    Blood; 2003 Jul; 102(1):184-91. PubMed ID: 12609848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Antiangiogenic Efficacy of Emilia sonchifolia (L.) DC on Tumor-Specific Neovessel Formation by Regulating MMPs, VEGF, and Proinflammatory Cytokines.
    Gilcy GK; Kuttan G
    Integr Cancer Ther; 2016 Dec; 15(4):NP1-NP12. PubMed ID: 27146127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.